| Year |
Citation |
Score |
| 2019 |
Knopp KL, Simmons RMA, Guo W, Adams BL, Gardinier KM, Gernert DL, Ornstein PL, Porter W, Reel J, Ding C, Wang H, Qian Y, Burris KD, Need A, Barth V, ... ... Nisenbaum ES, et al. Modulation of TARP γ8-containing AMPA Receptors as a Novel Therapeutic Approach for Chronic Pain. The Journal of Pharmacology and Experimental Therapeutics. PMID 30910921 DOI: 10.1124/Jpet.118.250126 |
0.341 |
|
| 2019 |
Wu B, McDermott J, Krajewski J, Knopp KL, Nisenbaum E, Cummins T, Tan Z. [EXPRESS] Extracellular signal-regulated kinases mediate the enhancing effects of inflammatory mediators on resurgent currents in dorsal root ganglion neurons. Molecular Pain. 1744806919837104. PMID 30803321 DOI: 10.1177/1744806919837104 |
0.317 |
|
| 2017 |
Copeland CS, Wall TM, Sims RE, Neale SA, Nisenbaum E, Parri HR, Salt TE. Astrocytes modulate thalamic sensory processing via mGlu2 receptor activation. Neuropharmacology. PMID 28416443 DOI: 10.1016/J.Neuropharm.2017.04.019 |
0.364 |
|
| 2014 |
Tan ZY, Piekarz AD, Priest BT, Knopp KL, Krajewski JL, McDermott JS, Nisenbaum ES, Cummins TR. Tetrodotoxin-resistant sodium channels in sensory neurons generate slow resurgent currents that are enhanced by inflammatory mediators. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 7190-7. PMID 24849353 DOI: 10.1523/Jneurosci.5011-13.2014 |
0.361 |
|
| 2011 |
Caraci F, Molinaro G, Battaglia G, Giuffrida ML, Riozzi B, Traficante A, Bruno V, Cannella M, Merlo S, Wang X, Heinz BA, Nisenbaum ES, Britton TC, Drago F, Sortino MA, et al. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective. Molecular Pharmacology. 79: 618-26. PMID 21159998 DOI: 10.1124/Mol.110.067488 |
0.353 |
|
| 2010 |
Kato AS, Gill MB, Ho MT, Yu H, Tu Y, Siuda ER, Wang H, Qian YW, Nisenbaum ES, Tomita S, Bredt DS. Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. Neuron. 68: 1082-96. PMID 21172611 DOI: 10.1016/J.Neuron.2010.11.026 |
0.357 |
|
| 2008 |
Kato AS, Siuda ER, Nisenbaum ES, Bredt DS. AMPA receptor subunit-specific regulation by a distinct family of type II TARPs. Neuron. 59: 986-96. PMID 18817736 DOI: 10.1016/J.Neuron.2008.07.034 |
0.322 |
|
| 2007 |
Kato AS, Zhou W, Milstein AD, Knierman MD, Siuda ER, Dotzlaf JE, Yu H, Hale JE, Nisenbaum ES, Nicoll RA, Bredt DS. New transmembrane AMPA receptor regulatory protein isoform, gamma-7, differentially regulates AMPA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 4969-77. PMID 17475805 DOI: 10.1523/Jneurosci.5561-06.2007 |
0.318 |
|
| 2007 |
Rorick-Kehn LM, Johnson BG, Burkey JL, Wright RA, Calligaro DO, Marek GJ, Nisenbaum ES, Catlow JT, Kingston AE, Giera DD, Herin MF, Monn JA, McKinzie DL, Schoepp DD. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039). The Journal of Pharmacology and Experimental Therapeutics. 321: 308-17. PMID 17204749 DOI: 10.1124/jpet.106.110809 |
0.322 |
|
| 2006 |
Alt A, Nisenbaum ES, Bleakman D, Witkin JM. A role for AMPA receptors in mood disorders. Biochemical Pharmacology. 71: 1273-88. PMID 16442080 DOI: 10.1016/J.Bcp.2005.12.022 |
0.315 |
|
| 2005 |
Johnson MP, Barda D, Britton TC, Emkey R, Hornback WJ, Jagdmann GE, McKinzie DL, Nisenbaum ES, Tizzano JP, Schoepp DD. Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). Psychopharmacology. 179: 271-83. PMID 15717213 DOI: 10.1007/s00213-004-2099-9 |
0.334 |
|
| 2004 |
Johnson MP, Nisenbaum ES, Large TH, Emkey R, Baez M, Kingston AE. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists. Biochemical Society Transactions. 32: 881-7. PMID 15494040 DOI: 10.1042/BST0320881 |
0.33 |
|
| 2003 |
Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, et al. LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease. The Journal of Pharmacology and Experimental Therapeutics. 306: 752-62. PMID 12730350 DOI: 10.1124/Jpet.103.049445 |
0.319 |
|
| 2002 |
Zhai J, Tian MT, Wang Y, Yu JL, Köster A, Baez M, Nisenbaum ES. Modulation of lateral perforant path excitatory responses by metabotropic glutamate 8 (mGlu8) receptors. Neuropharmacology. 43: 223-30. PMID 12213276 DOI: 10.1016/S0028-3908(02)00087-4 |
0.409 |
|
| 2001 |
Baumbarger PJ, Muhlhauser M, Zhai J, Yang CR, Nisenbaum ES. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator. The Journal of Pharmacology and Experimental Therapeutics. 298: 86-102. PMID 11408529 |
0.434 |
|
| 2001 |
Baumbarger P, Muhlhauser M, Yang CR, Nisenbaum ES. LY392098, a novel AMPA receptor potentiator: electrophysiological studies in prefrontal cortical neurons. Neuropharmacology. 40: 992-1002. PMID 11406190 DOI: 10.1016/S0028-3908(00)00195-7 |
0.504 |
|
| 1999 |
Gabel LA, Nisenbaum ES. Muscarinic receptors differentially modulate the persistent potassium current in striatal spiny projection neurons. Journal of Neurophysiology. 81: 1418-23. PMID 10085367 DOI: 10.1152/Jn.1999.81.3.1418 |
0.452 |
|
| 1998 |
Nisenbaum ES, Mermelstein PG, Wilson CJ, Surmeier DJ. Selective blockade of a slowly inactivating potassium current in striatal neurons by (+/-) 6-chloro-APB hydrobromide (SKF82958). Synapse (New York, N.Y.). 29: 213-24. PMID 9635891 DOI: 10.1002/(SICI)1098-2396(199807)29:3<213::AID-SYN3>3.0.CO;2-9 |
0.434 |
|
| 1998 |
Gabel LA, Nisenbaum ES. Biophysical characterization and functional consequences of a slowly inactivating potassium current in neostriatal neurons. Journal of Neurophysiology. 79: 1989-2002. PMID 9535963 DOI: 10.1152/Jn.1998.79.4.1989 |
0.398 |
|
| 1995 |
Nisenbaum ES, Wilson CJ. Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 4449-63. PMID 7790919 |
0.325 |
|
| 1995 |
Nisenbaum E, Wilson C. Potassium currents responsible for inward and outward rectification in rat neostriatal spiny projection neurons The Journal of Neuroscience. 15: 4449-4463. DOI: 10.1523/JNEUROSCI.15-06-04449.1995 |
0.317 |
|
| 1994 |
Nisenbaum ES, Xu ZC, Wilson CJ. Contribution of a slowly inactivating potassium current to the transition to firing of neostriatal spiny projection neurons. Journal of Neurophysiology. 71: 1174-89. PMID 8201411 |
0.325 |
|
| 1993 |
Bernath S, Zigmond MJ, Nisenbaum ES, Vizi ES, Berger TW. Na+ influx through Ca2+ channels can promote striatal GABA efflux in Ca(2+)-deficient conditions in response to electrical field depolarization. Brain Research. 632: 232-8. PMID 8149231 DOI: 10.1016/0006-8993(93)91158-O |
0.444 |
|
| 1993 |
Nisenbaum ES, Berger TW, Grace AA. Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors. Synapse (New York, N.Y.). 14: 221-42. PMID 8105549 DOI: 10.1002/syn.890140306 |
0.644 |
|
| 1992 |
Nisenbaum ES, Grace AA, Berger TW. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--II. In vitro analysis. Neuroscience. 48: 579-93. PMID 1351271 DOI: 10.1016/0306-4522(92)90403-O |
0.66 |
|
| 1992 |
Nisenbaum ES, Berger TW, Grace AA. Presynaptic modulation by GABAB receptors of glutamatergic excitation and GABAergic inhibition of neostriatal neurons. Journal of Neurophysiology. 67: 477-81. PMID 1349038 DOI: 10.1152/Jn.1992.67.2.477 |
0.628 |
|
| 1992 |
Nisenbaum ES, Berger TW. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs--I. In vivo analysis. Neuroscience. 48: 561-78. PMID 1318517 DOI: 10.1016/0306-4522(92)90402-N |
0.637 |
|
| 1988 |
Nisenbaum ES, Orr WB, Berger TW. Evidence for two functionally distinct subpopulations of neurons within the rat striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 8: 4138-50. PMID 3183715 DOI: 10.1523/Jneurosci.08-11-04138.1988 |
0.597 |
|
| 1988 |
Nisenbaum ES, Stricker EM, Zigmond MJ, Berger TW. Spontaneous activity of type II but not type I striatal neurons is correlated with recovery of behavioral function after dopamine-depleting brain lesions. Brain Research. 473: 389-93. PMID 3148358 DOI: 10.1016/0006-8993(88)90872-4 |
0.573 |
|
| 1986 |
Nisenbaum ES, Stricker EM, Zigmond MJ, Berger TW. Long-term effects of dopamine-depleting brain lesions on spontaneous activity of type II striatal neurons: relation to behavioral recovery. Brain Research. 398: 221-30. PMID 3099976 DOI: 10.1016/0006-8993(86)91481-2 |
0.519 |
|
| Show low-probability matches. |